Pharmacy on Web

10 February 2010

Due to to many adverse reactions being reported for Paradex and Capadex, which contains dextropropoxyphene, the government has decided to withdrawal it from the New Zealand market for public safety reason. The Medicnes Adverse Reactions Committee (MARC) recommended this as a result of their benefits verses risk review plus data from the NZ poisons centre.

More information available http://www.medsafe.govt.nz/hot/media/2010/QandACapadexandParadex.asp